CrohnProfile™ identifies your dominant immune pathways—IL-23, TNF-α, or mixed—so you start with the right medication from day one.
Your doctor picks a biologic and hopes it works. If not, you try another one 6 months later. Then another. Meanwhile, your disease progresses and permanent damage occurs.
Test your immune pathways before starting biologics. Know if you're IL-23 dominant (try Skyrizi), TNF-α driven (try Humira), or have mixed pathways (try Stelara). Start with the medication most likely to work for your immune system.
Select the level of analysis that's right for your situation
Core Panel
One-time payment
Newly diagnosed patients, those starting their first biologic, or patients considering treatment escalation.
Full Details →Enhanced Panel
One-time payment
Patients who failed multiple biologics, investigating why treatments aren't working, or preparing for surgery.
Full Details →Not sure which package is right for you?
Create a free account and get personalized recommendations →Choose CrohnProfile or CrohnProfile Plus. We ship a collection kit to your home with everything you need.
Visit a local lab for blood draw (or add at-home phlebotomy for $50). Collect stool sample for calprotectin.
Use prepaid shipping label to send samples to our CLIA-certified partner laboratory.
Comprehensive analysis of 32-53 biomarkers takes 10-14 business days.
Our AI identifies your dominant pathways and generates your personalized immune profile report.
Receive biologic matches ranked by compatibility score, plus clinical trial options and advocacy resources.
How CrohnProfile guides treatment selection
Sarah, 32 years old
Diagnosed with moderate Crohn's disease 6 months ago. Mesalamine and prednisone provided minimal relief. Doctor recommends starting a biologic but isn't sure which one.
Dominant Pathway: IL-23/IL-17 (Th17)
IL-23: 156 pg/mL (elevated)
IL-17A: 89 pg/mL (elevated)
TNF-α: 12 pg/mL (normal)
Calprotectin: 482 µg/g (high inflammation)
Outcome: Sarah started Skyrizi and achieved clinical remission within 12 weeks. She avoided 18+ months of trial-and-error with TNF-α inhibitors that wouldn't have worked for her IL-23-dominant pathways.
Stop guessing. Get your CrohnProfile and start with the biologic designed for YOUR immune system.
Order Your Panel →